Data to be presented in the Immunotherapy & Cell Therapy in Sarcoma: Emerging Frontiers session at the Connective Tissue Oncology Society ...

Ravin Ratan, MD, MEd, of The University of Texas MD Anderson Cancer Center, explains the origins of soft tissue sarcomas within the body—which account for 1% of cancers in adult patients—how ...

Sarcomas are rare and complex cancers that require specialised care. Diagnosing them can be challenging due to their rarity and similarity to other conditions.

With more than 12,000 cases and almost 5000 deaths yearly, soft-tissue sarcoma is owed greater attention, as revised guidelines and perspectives from experts attest.

There are many subtypes of the cancer, which develops in soft tissues such as fat, blood vessels, fibrous tissues or muscle. About one-half of all soft tissue sarcomas start in an arm or leg ...

A doctor may use an ultrasound scan to diagnose and assess a soft tissue sarcoma. Read about the procedure, results, and other diagnostic tests.

Investigators from Cedars-Sinai Cancer have discovered that cancerous tumors called soft-tissue sarcomas produce a protein that switches immune cells from tumor-attacking to tumor-promoting.

Against the backdrop of a case report, pembrolizumab was investigated as immunotherapy for undifferentiated pleomorphic soft tissue sarcoma.

Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the limb significantly improved disease-free survival, according to the ...

BOSTON — Excisional biopsies of soft tissue sarcoma of the hand are associated with more positive margins and a longer time to patients’ first intervention vs. incisional/needle biopsies ...

CHICAGO — A novel T-cell receptor therapy showed promising antitumor activity in patients with advanced soft tissue sarcoma, according to results from a phase 1 study presented at ASCO Annual ...